ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild-type p53 is modified

被引:0
|
作者
WesierskaGadek, J
BugajskaSchretter, A
Cerni, C
机构
[1] Inst. of Tumorbiology-Cancer Res., University of Vienna
[2] Inst. of Tumorbiology-Cancer Res., University of Vienna, A-1090 Vienna
关键词
p53; protein; ADP-ribosylation; rat cells; tumor suppressor protein;
D O I
10.1002/(SICI)1097-4644(199607)62:1<90::AID-JCB10>3.0.CO;2-J
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Poly(ADP-ribosyl)ation of mutant and wild-type p53 was studied in transformed and nontransformed rat cell lines constitutively expressing the temperature-sensitive p53(135val). It was found that in both cell types at 37.5 degrees C, where overexpressed p53 exhibits mutant conformation and cytoplasmic localization, a considerable part of the protein was poly(ADP-ribosyl)ated. Using densitometric scanning, the molecular mass of the modified protein was estimated as 64 kD. Immunofluorescence studies with affinity purified anti-poly(ADP-ribose) transferase (pADPRT) antibodies revealed that, contrary to predictions, the active enzyme was located in the cytoplasm, while in nuclei chromatin was depleted of pADPRT. A distinct intracellular localization and action of pADPRT was found in the cell lines cultivated at 32.5 degrees C, where p53 adopts wild-type form. Despite nuclear coexistence of both proteins no significant modification of p53 was found. Since the strikingly shared compartmentalization of p53 and pADPRT was indicative of possible complex Formation between the two proteins, reciprocal immunoprecipitation and immunoblotting were performed with anti-p53 and anti-pADPRT antibodies. A poly(ADP-ribosyl)ated protein of 116 kD constantly precipitated at stringent conditions was identified as the automodified enzyme. It is concluded that mutant cytoplasmic p53 is tighly complexed to pADPRT and becomes modified. At 32.5 degrees C binding to DNA of p53 or its temperature-dependent conformational alteration might prevent an analogous modification of the tumor suppressor protein. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:90 / 101
页数:12
相关论文
共 50 条
  • [1] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [2] ADP-ribosylation of wild-type p53 in vitro: Binding of p53 protein to specific p53 consensus sequence prevents its modification
    WesierskaGadek, J
    Schmid, G
    Cerni, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (01) : 96 - 102
  • [3] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    [J]. CELL, 1991, 65 (05) : 765 - 774
  • [4] Chaperoning of Mutant p53 Protein by Wild-type p53 Protein Causes Hypoxic Tumor Regression
    Gogna, Rajan
    Madan, Esha
    Kuppusamy, Periannan
    Pati, Uttam
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2907 - 2914
  • [5] The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
    Cadwell, C
    Zambetti, GP
    [J]. GENE, 2001, 277 (1-2) : 15 - 30
  • [6] Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation
    Kaypee, Stephanie
    Sahadevan, Smitha Asoka
    Patil, Shilpa
    Ghosh, Piya
    Roy, Neeladri Sekhar
    Roy, Siddhartha
    Kundu, Tapas K.
    [J]. ISCIENCE, 2018, 4 : 260 - +
  • [7] Activities of wild-type and mutant p53
    Vousden, Karen H.
    [J]. CANCER RESEARCH, 2013, 73
  • [8] Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
    Wu, Jianyuan
    Li, Qingdi Quentin
    Zhou, Huiping
    Lu, Yinying
    Li, Jueli M.
    Ma, Yao
    Wang, Li
    Fu, Tingting
    Gong, Xingjiang
    Weintraub, Michael
    Wu, Shuangchan
    Ding, Hong
    [J]. MEDICAL ONCOLOGY, 2014, 31 (07)
  • [9] Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
    Jianyuan Wu
    Qingdi Quentin Li
    Huiping Zhou
    Yinying Lu
    Jueli M. Li
    Yao Ma
    Li Wang
    Tingting Fu
    Xingjiang Gong
    Michael Weintraub
    Shuangchan Wu
    Hong Ding
    [J]. Medical Oncology, 2014, 31
  • [10] Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins
    Moos, PJ
    Edes, K
    Fitzpatrick, FA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) : 9215 - 9220